Company / R&D per Share
PULSE BIOSCIENCES, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.68
FY2025
5-year range
$0.56 / $1.12
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#81 of 108
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s r&d per share of $0.68 is lower than 75% of companies in the Health Care sector (FY2025). Improved from $0.56 to $0.68 over the past 2 years.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -9.8%.
Improved from $0.56 to $0.68 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- -9.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 108This company $0.68 Sector average $2.07
▼
-67.3% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 15.7% year-over-year.
- Ranks #81 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | +15.7% |
| FY2024 | $0.59 | +4.8% |
| FY2023 | $0.56 | -20.2% |
| FY2022 | $0.70 | -37.4% |
| FY2021 | $1.12 | -1.5% |
| FY2020 | $1.14 | -5.5% |
| FY2019 | $1.20 | +19.1% |
| FY2018 | $1.01 | +54.5% |
| FY2017 | $0.65 | +30.7% |
| FY2016 | $0.50 | +73.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026